Cargando…
Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination
We describe a patient who developed bilateral oculomotor nerve palsy, ataxia, facial diplegia and lower limb weakness 2 weeks post-Oxford-AstraZeneca SARS-CoV2 vaccination, consistent with Miller-Fisher syndrome (MFS) and Guillain-Barre syndrome (GBS) overlap syndrome. Although some features of the...
Autores principales: | Dang, Yew Li, Bryson, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634230/ https://www.ncbi.nlm.nih.gov/pubmed/34848426 http://dx.doi.org/10.1136/bcr-2021-246701 |
Ejemplares similares
-
Miller–Fisher syndrome after first dose of Oxford/AstraZeneca coronavirus disease 2019 vaccine: a case report
por: Pirola, Fernanda Junqueira Cesar, et al.
Publicado: (2022) -
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
por: Oo, Wai M., et al.
Publicado: (2021) -
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
por: Introna, Alessandro, et al.
Publicado: (2021) -
A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination
por: Bazrafshan, Hanieh, et al.
Publicado: (2022) -
Guillain-Barré and Miller Fisher Overlap Syndrome Mimicking Alimentary Botulism
por: Legast, Gabriela Moreno, et al.
Publicado: (2017)